计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| S288762-1mg |
1mg |
现货 ![]() |
| |
| S288762-5mg |
5mg |
现货 ![]() |
| |
| S288762-10mg |
10mg |
现货 ![]() |
| |
| S288762-25mg |
25mg |
现货 ![]() |
| |
| S288762-50mg |
50mg |
现货 ![]() |
| |
| S288762-100mg |
100mg |
现货 ![]() |
|
| 别名 | N-(2-溴苯基)-N'-(7-氰基-1H-苯并三唑-4-基)脲 |
|---|---|
| 英文别名 | SB 265610; SB265610 | NCGC00242491-02 | Urea, N-(2-bromophenyl)-N'-(4-cyano-1H-benzotriazol-7-yl)- | Q27272851 | DTXSID10175339 | BCP28242 | 1-(2-Bromophenyl)-3-(4-cyano-1H-benzo[d][1,2,3]triazol-7-yl)urea | AC-36981 | AKOS024457259 | MS-25597 | 1-(2-brom |
| 规格或纯度 | ≥98%(HPLC) |
| 英文名称 | SB 265610 |
| 生化机理 | 抑制CINC-1介导但不抑制C5a介导的Ca2 +动员的有效CXCR2拮抗剂(IC50值分别为3.4和6800 nM)。体内抑制CINC诱导的趋化性并减弱炎症性肺损伤中的中性粒细胞积聚。 |
| 储存温度 | 避光,-20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
SB-265610 是一种选择性的竞争性非肽变构 CXCR2 拮抗剂。SB-265610 阻断大鼠 CINC-1 诱导的钙动员和中性粒细胞趋化性,IC50 分别为 3.7 nM 和 70 nM。 application: SB265610 has been used: as a cysteine-amino acid-cysteine (CXC)-chemokine receptor type 2 (CXCR2) antagonist to study its effects on the binding of chemokine with G-protein coupled receptors (GPCR) as a CX-chemokine receptor type 1 (CXCR1) inhibitor to study its effect on the chemotactic activity of chemokines on inflammatory cells as a CXCR2 antagonist to study its effect on migration of neutrophils to the rat brain |
| 纯度 | ≥98%(HPLC) |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 1-(2-bromophenyl)-3-(7-cyano-2H-benzotriazol-4-yl)urea |
| INCHI | 1S/C14H9BrN6O/c15-9-3-1-2-4-10(9)17-14(22)18-11-6-5-8(7-16)12-13(11)20-21-19-12/h1-6H,(H2,17,18,22)(H,19,20,21) |
| InChi Key | SEDUMQWZEOMXSO-UHFFFAOYSA-N |
| Smiles | C1=CC=C(C(=C1)NC(=O)NC2=CC=C(C3=NNN=C23)C#N)Br |
| Isomeric SMILES | C1=CC=C(C(=C1)NC(=O)NC2=CC=C(C3=NNN=C23)C#N)Br |
| PubChem CID | 9841667 |
| 分子量 | 357.16 |
| 溶解性 | 溶于DMSO, 最高浓度 (mg/mL): 35.72, 最高浓度(mM): 100;溶于ethanol, 最高浓度 (mg/mL): 3.57, 最高浓度(mM): 10 |
|---|---|
| 敏感性 | 对光线敏感 |
| 分子量 | 357.160 g/mol |
| XLogP3 | 2.000 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 4 |
| 可旋转键计数Rotatable Bond Count | 2 |
| 精确质量Exact Mass | 356.002 Da |
| 单同位素质量Monoisotopic Mass | 356.002 Da |
| 拓扑极表面积Topological Polar Surface Area | 106.000 Ų |
| 重原子数Heavy Atom Count | 22 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 465.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H302: 吞食有害 |
| 预防措施声明 |
P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P330: 漱口 P301+P312: 如误吞咽:如感觉不适,呼叫急救中心/医生。 P501: 将内容物/容器处理到。。。 |
| 1. Hu Songliu, Zhan Ning, Li Jian, Wang Liqun, Liu Yiyan, Jin Ke, Wang Yixuan, Zhang Juxuan, Chen Yiyang, Bai Yang, Wang Yichong, Qi Lishuang, Liu Shilong. (2025) RBM15 recruits myeloid-derived suppressor cells via the m6A-IGF2BP3/CBR3-AS1/miR-409-3p/CXCL1 axis, facilitating radioresistance in non-small-cell lung cancer. Journal of Translational Medicine, 23 (1): (1-19). [PMID:39962467] [10.1186/s12967-025-06205-y] |